Indicative of a therapeutic window, studies in mice using a BiTE binding to murine EpCAM and murine CD3 demonstrated anti-tumor activity in the absence of damage to EpCAM-expressing normal epithelia [37], [41], [42] . The gene discussed is EPCAM; the disease is neoplasm.